Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Actuate Therapeutics, Inc. (ACTU) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Actuate Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1652935.
Total stock buying since 2024: $13,499,988.
Total stock sales since 2024: $824,973.
Total stock option exercises since 2024: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 214,284 | $1,499,988 | 0 | $0 | 0 | $0 |
| 2024 | 1,500,000 | $12,000,000 | 93,747 | $824,973 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 214,284 | $1,499,988 | 0 | $0 | 0 | $0 |
| 2024-08 | 1,500,000 | $12,000,000 | 93,747 | $824,973 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-27 | Bios Equity Partners Iii, Lp | Buy | 71,428 | 7.00 | 499,996 |
| 2025-06-27 | Bios Equity Partners Ii, Lp | Buy | 71,428 | 7.00 | 499,996 |
| 2025-06-27 | Bp Directors, Lp | Buy | 71,428 | 7.00 | 499,996 |
| 2024-08-14 | Kairos-actuate Spv, L.p. | Sale | 18,750 | 8.00 | 150,000 |
| 2024-08-14 | Bios Equity Partners Iii, Lp | Buy | 500,000 | 8.00 | 4,000,000 |
| 2024-08-14 | Bios Equity Partners Iii, Lp | Sale | 24,999 | 9.00 | 224,991 |
| 2024-08-14 | Bios Equity Partners Ii, Lp | Buy | 500,000 | 8.00 | 4,000,000 |
| 2024-08-14 | Bios Equity Partners Ii, Lp | Sale | 24,999 | 9.00 | 224,991 |
| 2024-08-14 | Bp Directors, Lp | Buy | 500,000 | 8.00 | 4,000,000 |
| 2024-08-14 | Bp Directors, Lp | Sale | 24,999 | 9.00 | 224,991 |
Insider trading activities including stock purchases, stock sales, and option exercises of ACTU listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Actuate Therapeutics, Inc. (symbol ACTU, CIK number 1652935) see the Securities and Exchange Commission (SEC) website.